Pulmonary embolism in patients with COVID-19 and its treatment based on low-molecular-weight heparin

Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 2020;92(6):568-76. PMID: 32134116; doi: 10.1002/jmv.25748.

Jin Y, Yang H, Ji W, Wu W, et al. Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses. 2020;12(4): E372. PMID: 32230900; doi: 10.3390/v12040372.

Grillet F, Behr J, Calame P, Aubry S, Delabrousse E. Acute pulmonary embolism associated with COVID-19 pneumonia detected by pulmonary CT angiography [published online ahead of print, 2020 Apr 23] . Radiology. 2020;201544. PMID: 32324103; doi: 10.1148/radiol.2020201544 .

Poissy J, Goutay J, Caplan M, et al. Pulmonary embolism in COVID-19 patients: awareness of an increased prevalence. Circulation. 2020;142(2):184-6. PMID: 32330083; doi: 10.1161/CIRCULATIONAHA.120.047430.

Leonard-Lorant I, Delabranche X, Severac F, et al. Acute pulmonary embolism in COVID-19 patients on CT angiography and relationship to D-dimer levels [published online ahead of print, 2020 Apr 23]. Radiology. 2020;201561. PMID: 32324102; doi: 10.1148/radiol.2020201561.

Zotzmann V, Lang CN, Bamberg F, Bode C, Staudacher DL. Are subpleural consolidations indicators for segmental pulmonary embolism in COVID-19? Intensive Care Med. 2020;46(6):1109-10. PMID: 32328727; doi: 10.1007/s00134-020-06044-z.

Cellina M, Oliva G. Acute pulmonary embolism in a patient with COVID-19 pneumonia. Diagn Interv Imaging. 2020;101(5):325-6. PMID: 3303472; doi: 10.1016/j.diii.2020.04.001.

Danzi GB, Loffi M, Galeazzi G, Gherbesi E. Acute pulmonary embolism and COVID-19 pneumonia: a random association? Eur Heart J. 2020;41(19):1858. PMID: 32227120; doi: 10.1093/eurheartj/ehaa254.

York NL, Kane CJ, Smith C, Minton LA. Care of the patient with an acute pulmonary embolism. Dimens Crit Care Nurs. 2015;34(1):3-9. PMID: 25470260; doi: 10.1097/DCC.0000000000000082.

Tang N, Bai H, Chen X, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5)1094-9. PMID: 32220112; doi: 10.1111/jth.14817.

Wujtewicz M, Dylczyk-Sommer A, Aszkielowicz A, et al. COVID-19 - what should anaethesiologists and intensivists know about it? Anaesthesiol Intensive Ther. 2020;52(1):34-41. PMID: 32191830; doi: 10.5114/ait.2020.93756.

Farnoosh G, Alishiri G, Hosseini Zijoud SR, Dorostkar R, Jalali Farahani A. Understanding the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease (COVID-19) based on available evidence − a narrative review. J Mil Med. 2020;22(1):1-11. doi: 10.30491/JMM.22.1.1.

Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease − Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines [published correction appears in Chest. 2012 Dec;142(6):1698-1704]. Chest. 2012;141(2 Suppl): e419S-e496S. PMID: 22315268; doi: 10.1378/chest.11-2301.

Llitjos JF, Leclerc M, Chochois C, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020;18(7):1743-6. PMID: 32320517; doi: 10.1111/jth.14869.

Tersalvi G, Vicenzi M, Calabretta D, et al. Elevated troponin in patients with coronavirus disease 2019 (COVID-19): possible mechanisms. J Card Fail. 2020;26(6):470-5. PMID: 32315733; doi: 10.1016/j.cardfail.2020.04.009.